Furthermore, to gain insights into the metabolic differences between tumor and NAT tissues, we conducted LC–MS untargeted metabolomics analysis on 26 paired samples from 13 AEG patients (Figure 1A; Supplementary Table S1). The gene discussed is BRD2; the disease is neoplasm.